Strasbourg, December 17, 2021 - 05:45 pm CET
TRANSGENE (Paris: TNG) today announces that Management will participate in the upcoming investor events set out below.
Transgene will meet institutional investors at the 11th Annual LifeSci Advisors Corporate Access Event (virtual event) from January 5th to 7th, 2022.
The Company will also attend:
• 25th ODDO BHF Digital Forum (virtual): January 6, 7, 10 and 11, 2022
• Biotech Showcase Investor Conference (virtual):
- January 10 to 12, 2022, in conjunction with the J.P. Morgan Healthcare conference
- January 17 to 19, 2022
• Biomed Event (Paris): January 26, 2022
.../...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer